In this free webinar, learn how nanopore sequencing is transforming biopharmaceutical development with real-time genetic analysis. Attendees will gain insight into its expanding applications beyond traditional uses, including RNA analysis and good manufacturing practice (GMP) environments. The featured speakers will discuss integrating nanopore technology to complement existing analytical methods. The speakers will also share how this technology can optimize processes, accelerate delivery timelines and enhance efficiency in drug development and manufacturing.

Advancements in sequencing technologies are reshaping biopharmaceutical development, with nanopore sequencing emerging as a powerful tool for real-time genetic analysis. While traditionally seen as a niche solution, its unique ability to offer real-time, scalable and portable sequencing has made it a game changer in various fields.

This session will explore how nanopore sequencing is evolving beyond its established applications, including its future role in RNA analysis and its growing adoption in good manufacturing practice (GMP) environments. In this webinar, the expert speakers will discuss how nanopore technology can complement and enhance traditional analytical methods, offering new opportunities in process development and quality control.

Register for the webinar to gain insights into how nanopore sequencing is poised to become a key player in the biopharma industry and how it can be leveraged in drug development and manufacturing.

Join expert speakers Michaël Lambin, Development Tech Lead Manager, Exothera; Wei Rong, Senior Analytical Scientist, Exothera; and Olivier Lucas, PhD, Director, Biopharma Sales, Oxford Nanopore Technologies, for the live webinar on Wednesday, March 26, 2025, at 11am EDT (4pm CET/EU-Central).

For more information, or to register for this event, visit Nanopore Sequencing for RNA Vaccines and Therapeutics: Advancing Drug Development and Quality Control.

Source – PRNewswire